- Home
- KROS vs CGNT Comparison
KROS vs CGNT Comparison
Compare KROS & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- CGNT
- Stock Information
- Founded
- KROS 2015
- CGNT 2020
- Country
- KROS United States
- CGNT Israel
- Employees
- KROS N/A
- CGNT N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- KROS Health Care
- CGNT Technology
- Exchange
- KROS Nasdaq
- CGNT Nasdaq
- Market Cap
- KROS 565.0M
- CGNT 657.1M
- IPO Year
- KROS 2020
- CGNT N/A
- Fundamental
- Price
- KROS $15.66
- CGNT $8.52
- Analyst Decision
- KROS Buy
- CGNT Hold
- Analyst Count
- KROS 14
- CGNT 1
- Target Price
- KROS $20.56
- CGNT N/A
- AVG Volume (30 Days)
- KROS 430.7K
- CGNT 291.0K
- Earning Date
- KROS 11-05-2025
- CGNT 09-09-2025
- Dividend Yield
- KROS N/A
- CGNT N/A
- EPS Growth
- KROS N/A
- CGNT N/A
- EPS
- KROS 0.47
- CGNT N/A
- Revenue
- KROS $232,844,000.00
- CGNT $376,566,000.00
- Revenue This Year
- KROS $5,579.44
- CGNT $14.94
- Revenue Next Year
- KROS N/A
- CGNT $9.57
- P/E Ratio
- KROS $33.65
- CGNT N/A
- Revenue Growth
- KROS 85820.30
- CGNT 14.04
- 52 Week Low
- KROS $9.12
- CGNT $6.24
- 52 Week High
- KROS $72.37
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- CGNT 45.45
- Support Level
- KROS $15.23
- CGNT $8.15
- Resistance Level
- KROS $15.85
- CGNT $8.81
- Average True Range (ATR)
- KROS 0.52
- CGNT 0.32
- MACD
- KROS 0.01
- CGNT -0.01
- Stochastic Oscillator
- KROS 72.91
- CGNT 26.06
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.